News archive search
Search the Newsreel
Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.
- Showing
- 145–180
- Matches
- 842
- Sources here
- 22
- Companies here
- 15
Active search
842 matching headlines
Search results
Matching headlines
External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.
IMDX Looks 289.5% Overvalued on GF Value™
Insight Molecular Diagnostics Inc (IMDX) is considered 284.7% overvalued based on its GF Value™ despite optimism around future FDA authorization for its GraftAssureDx test and expanded Medicare reimbursement. The company reported a Q2 adjusted EBITDA loss and an upward revision of its cash burn …
Insight Molecular Diagnostics Q2 2026 Earnings Preview
* Insight Molecular Diagnostics Inc. (IMDX [https://seekingalpha.com/symbol/IMDX]) is scheduled to announce Q2 earnings results on Monday, August 10th, after market close. * The consensus EPS estimate is -$0.25, [https://seekingalpha.com/symbol/IMDX/earnings/estimates] and the consensus revenue estimate is $0.44M * Over the last year, IMDX has beaten …
Sonos, Inc. (SONO) Stock Forecasts
Argus has lowered its target price for Sonos, Inc. (SONO) to $17.00, while the stock is currently trading at $15.77. Sonos specializes in home sound systems, including speakers and various accessories. Investors can upgrade to premium services for detailed research reports and trade insights.
Is Innospec (IOSP) Still Undervalued After Its Q2 Earnings Beat?
Find your next quality investment with Simply Wall St's easy and powerful screener, trusted by over 7 million individual investors worldwide. Innospec stock has climbed 21.2% year to date, yet the latest valuation work suggests the current share price may still sit below an …
Innospec Inc. 2026 Q2 - Results - Earnings Call Presentation (NASDAQ:IOSP) 2026-08-08
Innospec Inc. (IOSP) has published its Q2 2026 earnings call presentation, detailing its financial results for the quarter. The company reported an EPS of $1.27, surpassing estimates by $0.22, and revenue of $491.40 million, which beat expectations by $34.17 million and represents an 11.76% …
Co-Diagnostics Submits Co-Dx PCR Flu A/B & RSV Test for FDA Clearance
Co-Diagnostics has submitted its Co-Dx PCR Flu A/B & RSV multiplex respiratory test for FDA clearance, including a dual 510(k) premarket notification and a CLIA Waiver by Application. This submission is backed by extensive clinical studies involving over 1,400 patients and an analytical program …
Kronos Worldwide (NYSE:KRO) Rating Increased to Buy at Wall Street Zen
Wall Street Zen has upgraded Kronos Worldwide (NYSE:KRO) from a "Hold" to a "Buy" rating, despite a broader analyst consensus of "Hold" with a $5.00 target price. The company's shares opened at $8.55, near their 52-week high, following a strong earnings report where EPS …
Ainos, Inc. (AIMD) Stock Price, News, Quote & History
This Yahoo Finance page provides comprehensive information on Ainos, Inc. (AIMD), a company focused on AI-based smelltech and immune therapeutics. It includes real-time stock price data, historical performance, company overview, financial highlights, and comparisons with similar companies in the Scientific & Technical Instruments industry. …
Century Casinos (NASDAQ: CNTY) hits record Q2 revenue but remains in loss
Century Casinos, Inc. reported record second-quarter 2026 net operating revenue of $151.995 million and Adjusted EBITDAR of $31.660 million, marking increases of 1% and 5% respectively year over year. Despite this revenue growth, the company remained unprofitable, with a net loss attributable to shareholders …
CHRN Price History for Chronoscale Holdings Corp Stock
This article provides historical price data for Chronoscale Holdings Corp (CHRN) stock on Barchart.com, including daily prices, latest trades, and corporate actions. It details 52-week high/low points, Fibonacci levels, and the frequency of new highs and lows over various periods. The site offers comprehensive …
Cardio Diagnostics (NASDAQ: CDIO) Q2 2026 shows $5.6M cash and equity funding
Cardio Diagnostics Holdings, Inc. (NASDAQ: CDIO) reported a Q2 2026 net loss of $1.5 million on revenues of $5,360, with cash reserves of $5.6 million. The company continues to fund operations primarily through equity, having raised $3.7 million from at-the-market share sales in 2026, …
Cardio Diagnostics Holdings, Inc. 2026: Revenue $5.36K, EPS ($0.51) — 10-Q Summary
Cardio Diagnostics Holdings, Inc. reported nominal revenue of $5.36K and a diluted loss per share of ($0.51) for the 2026 quarter, reflecting its early commercialization stage and ongoing investments. The company is shifting its go-to-market strategy to non-reimbursement channels and has made progress with …
Century Casinos, Inc. Announces Second Quarter 2026 Results
Century Casinos, Inc. (Nasdaq Capital Market®: CNTY) announced its financial results for the second quarter ended June 30, 2026, reporting an all-time record Q2 net operating revenue of $152.0 million, a 1% increase, and Adjusted EBITDAR of $31.7 million, a 5% increase compared to …
Quest Diagnostics Inc (DGX) Stock News Today
This article from TradingKey provides a news page for Quest Diagnostics Inc (DGX) stock. It includes current stock performance metrics like price, market cap, and P/E ratio. The page indicates that more news will be coming soon regarding DGX stock.
Avanos Medical Inc (AVNS) Earnings Forecast: Future EPS & Revenue Growth Estimates
Avanos Medical Inc (AVNS) has an earnings forecast score of 6.00, placing it 174th in the Healthcare Equipment & Supplies industry. Analysts have set a target price of $14.00 for AVNS, with one analyst recommending a "Hold" rating. The company's expected revenue for the …
Ainos Inc (AIMD) Stock News Today
This article provides current stock information for Ainos Inc (AIMD), including its stock price, market capitalization, and a brief overview of available financial data and news categories. It indicates that more news content for AIMD will be published soon. The page serves as a …
Director grant at Cronos Group Inc. (CRON) adds deferred share units
Cronos Group Inc. director James Daniel Rudyk was granted 48,859.9300 Deferred Share Units (DSUs) on August 6, 2026, bringing his total direct holdings to 362,742.2200 DSUs. These DSUs entitle him to a lump-sum cash payment equal to the fair market value of a Cronos …
Cronos Group Inc. (CRON) director receives deferred share unit award
Cronos Group Inc. director Jason Marc Adler was granted 48,859.93 Deferred Share Units, bringing his total holdings to 362,742.22 units. These units are cash-settled based on the fair market value of Cronos Group common shares upon redemption, which occurs after he ceases to be …
Deferred share unit grant for Cronos Group Inc. (CRON) director Garnick
Cronos Group Inc. director Murray R. Garnick was granted 48,859.93 Deferred Share Units on August 6, 2026. These units are cash-settled, meaning upon redemption, Garnick will receive a cash payment equal to the fair market value of Cronos common shares. Following this grant, his …
Kronos Worldwide (KRO) Stock Rebounds On Profit Return But Losses Linger
Kronos Worldwide (KRO) saw its stock rise by 32.2% after reporting a return to profit in Q2 2026, with revenue increasing to US$558.1m and net income reaching US$15.2m. Despite this positive quarterly performance, the company's trailing 12-month net income still shows a significant loss …
Century Casinos, Inc. Q2 2026 Earnings Call Summary
Century Casinos, Inc. Q2 2026 Earnings Call Summary - Moby Strategic Performance and Operational Drivers Our analysts just identified a stock with the potential to be the next Nvidia. Tell us how you invest and we'll show you why it's our #1 pick. Tap …
Century Casinos Inc (CNTY) (Q2 2026) Earnings Call Highlights: Record Revenue and Strategic ...
Century Casinos Inc. (CNTY) reported record Q2 2026 net operating revenue of $152 million and adjusted EBITDAR of $31.7 million, with strong growth in North American operations, particularly at the Nugget property. Despite challenges in Poland and competitive pressures at Rocky Gap, the company …
Century Casinos Releases Q2 2026 Financial Results
Century Casinos, Inc. (CNTY) reported a Q2 2026 diluted loss of $0.39 per share, wider than the $0.34 loss expected by analysts, and a net loss of $10.9M on revenues of $152.0M. Despite the wider loss compared to analyst expectations, the per-share loss narrowed …
Century Casinos Q2 2026 slides: record results, 93% West region growth
Century Casinos Inc. reported record second-quarter 2026 results, with net operating revenue of $152 million and adjusted EBITDAR of $31.7 million, largely driven by a 93% growth in its West region. The company's North American properties, especially the Nugget Casino Resort in Nevada, significantly …
Is Innospec (IOSP) Stock Outpacing Its Basic Materials Peers This Year?
For those looking to find strong Basic Materials stocks, it is prudent to search for companies in the group that are outperforming their peers. Innospec (IOSP) is a stock that can certainly grab the attention of many investors, but do its recent returns compare …